World of DTC Marketing
DECEMBER 29, 2021
The demand quickly exceeded supply after the FDA approved once-weekly semaglutide injections. Semaglutide’s study results were enough to warrant plenty of hype for obesity treatment. The drug got a PR boost from Marc Andreessen, who called semaglutide a “silver bullet” and “miracle drug” for suppressing appetite. Unfortunately, the hype is going to exceed reality.
pharmaphorum
DECEMBER 30, 2021
Johnson & Johnson’s much-touted crop of bispecific antibodies for cancer generated its first commercial product in May, and the drugmaker has now filed for FDA approval of a second candidate. The latest to reach the regulatory stage is teclistamab, one of two bispecifics for multiple myeloma in the late-stage pipeline of J&J’s Janssen division stemming from its longstanding and fertile collaboration with Danish biotech Genmab.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
XTalks
DECEMBER 28, 2021
Each year, Google reveals its annual list of top food searches, which are representative of the most popular food trends and recipes of the year. With half of this year’s list stemming from either celebrities or social media, it is clear that “going viral” has a major impact on what consumers are searching for. Here are the top ten food searches from Google in 2021 and what they reveal about the current status of the food and beverage industry.
Scienmag
DECEMBER 27, 2021
The Coronavirus SARS-CoV-2 infects the kidneys and contributes to tissue scarring, as shown by researchers from the RWTH Uniklinik Aachen, Germany, and Radboudumc, The Netherlands. The developed scar tissue in the infected kidneys may suggest a possible impact on kidney outcomes in the long term. Credit: Jitske Jansen and Bart Smeets, Radboudumc The Coronavirus SARS-CoV-2 […].
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
World of DTC Marketing
DECEMBER 30, 2021
Routine cancer screening is essential to detect cancers early when it is most curable. The consequence of millions of people missing cancer screenings because of the COVID pandemic is a delay in detecting cancer, which results in cancer progressing to a more advanced stage. According to a study published in JAMA Oncology, a publication of the American Medical Association, nearly 22 million cancer screenings in the U.S. failed to happen because of the COVID-19 pandemic.
pharmaphorum
DECEMBER 29, 2021
Sanofi and Regeneron have another challenger to their big-selling drug Dupixent for atopic dermatitis, now that the FDA has approved Leo Pharma’s rival antibody tralokinumab. IL-13 inhibitor tralokinumab has been cleared by the US regulator as Adbry as a treatment for moderate-to-severe atopic dermatitis in adults who can’t control symptoms using topical prescription therapies.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
Scienmag
DECEMBER 27, 2021
PHILADELPHIA — Penn Medicine has been awarded a prestigious seven-year, $14 million grant from the National Institutes of Health (NIH) to promote organ transplantation for patients with end-stage renal disease who are currently on the waitlist for a kidney transplant. The team will launch a clinical trial harnessing synthetic chimeric antigen receptor (CAR) T cells […].
JAMA Internal Medicine
DECEMBER 27, 2021
This cohort study compares COVID-19 incidence, risk, outcome severity, and treatment response between immunocompromised individuals and those without immune dysfunction conditions before and after SARS-CoV-2 vaccination.
XTalks
DECEMBER 29, 2021
Bayer has announced that all of its products will have 100 percent green packaging by 2030. The pharma giant says it will be investing €100 million towards achieving this target, which is part of the company’s sustainability program aimed at helping to protect the environment and combat climate change. This means all of the company’s over-the-counter (OTC) drugs and supplements such as pain, allergy and cold medications, and vitamins will have brand packaging that is 100 percent recyclable or re
NY Times
DECEMBER 30, 2021
The case was the first of its kind, targeting every point of the prescription opioid supply chain, from manufacturers to pharmacy chains that filled prescriptions.
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
Scienmag
DECEMBER 27, 2021
A team of researchers at the University of Adelaide has found a link between the way that cells produce energy for brain function and the mutated genes found in Alzheimer’s disease. Credit: Pixabay. Photo by Pete Linforth. A team of researchers at the University of Adelaide has found a link between the way that cells […].
pharmaphorum
DECEMBER 31, 2021
The jury in a new York trial has found that Teva Pharmaceuticals played a role in fuelling the opioid crisis in the US, and should be held liable for damages, which will be decided later. The decision came after eight days of deliberation by the jurors, and almost six months of legal jousting between the drugmaker and its counsel and lawyers for the state of New York and two of its counties, Suffolk and Nassau.
Cloudbyz
DECEMBER 31, 2021
Wearable Tech-What’s It All About? Let’s start from the very beginning. What are people talking about when they say “wearables”, “wearable biosensors”, “wearable devices”, or “wearable technology” in clinical trials? In the most basic sense, all these terms refer to relatively mobile devices that you can wear on your person; designed to measure specific biological parameters in your body.
NY Times
DECEMBER 30, 2021
Regulators will also allow even younger children with immune deficiencies to get an extra shot.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Scienmag
DECEMBER 25, 2021
In one of the most exciting developments in astronomy in the 21st century, NASA is launching the James Webb Space Telescope (JWST) today—and Northern Arizona University astronomers, planetary astronomers and their students will be using the massive observatory to expand their research and advance our understanding of the solar system. Credit: Credit: Ball Aerospace In […].
Drug Patent Watch
DECEMBER 30, 2021
[
BioTech 365
DECEMBER 30, 2021
Leonhardt Ventures Files Patent for Bioelectric Diabetes Reversal Treatment via FABp4 Regulation and Klotho Regulation Leonhardt Ventures Files Patent for Bioelectric Diabetes Reversal Treatment via FABp4 Regulation and Klotho Regulation Mission Viejo, California, United States, Dec.
NY Times
DECEMBER 31, 2021
Medicare officials are trying to determine whether to cover Aduhelm, which the F.D.A. approved despite unclear evidence that it helps patients.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Scienmag
DECEMBER 27, 2021
Cylindrical vector beam (CVB) multiplexing has emerged as a powerful technique to boost signal channels. Coupling and separating CVBs are two pivotal elements in CVB multiplexing communication. Although off-axis control technologies, such as miniature Dammann vortex gratings, have been investigated to couple and separate light beams, it is usually limited to light beams with homogeneous […].
Pharma Packaging Solutions
DECEMBER 30, 2021
Central’s Chrismon Tree began in 1977, when the women of the church made the first ornaments for our church tree. The number of Christian Christmas symbols on our tree has grown each year until we now have over one hundred. Our Chrismons are made in white, the liturgical color of Christmas, which refers to Christ’s purity and perfection, and gold, which refers to his majesty and glory.
BioTech 365
DECEMBER 29, 2021
Leonhardt Ventures Announces Filing of Patent for Bioelectric S100A Expression for Organ Healing Leonhardt Ventures Announces Filing of Patent for Bioelectric S100A Expression for Organ Healing Mission Viejo, California, United States, Dec.
NY Times
DECEMBER 28, 2021
Un tratamiento que puede ayudar a la gente que necesita anteojos para ver de cerca, sin afectar su visión de largo alcance, salió al mercado en diciembre tras ser aprobado por la FDA en octubre.
Advertisement
When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.
Scienmag
DECEMBER 28, 2021
Dementia is thought to occur when proteins called amyloid-?, tau, and ?-synuclein accumulate in the brain and form oligomers. A research group from the Department of Translational Neuroscience, Osaka City University Graduate School of Medicine, had previously shown in a study using mice that the antibiotic rifampicin removes oligomers from the brain and improves cognitive […].
Pharma Packaging Solutions
DECEMBER 30, 2021
2022! A fresh year, we hope. A new start, we pray. A chance to leave past pain and struggle in the past. But what are we moving toward? What are our dreams and aspirations, especially as a community of faith? Dare we ask what are God’s dreams for us as a community of faith? Our theme for 2022 is “Jesus 365.” We begin the year with a journey through Luke’s gospel, picking up the story this Sunday when Jesus is 12 years old and left behind in Jerusalem.
Drug Patent Watch
DECEMBER 29, 2021
Annual Drug Patent Expirations for MAVYRET Mavyret is a drug marketed by Abbvie Inc and is included in two NDAs. It is available from one supplier. There are seven patents…. The post New patent for Abbvie Inc drug MAVYRET appeared first on DrugPatentWatch - Make Better Decisions.
Pharma Tutor
DECEMBER 27, 2021
AROMATASE INHIBITORS IN BREAST CANCER. About Authors. MANISHA KOTADIYA*, JAYDEEP SAVALIYA. *Shree Swaminarayan Sanskar Collage of Pharmacy Zundal, Gandhinagar, Gujarat, Email Id: manishakotadiya3@gmail.com, FTF Pharma Pvt. Ltd. – Ahmedabad, Email ID: jaydeepsavaliya27@gmail.com. DOWNLOAD AS PDF. admin. Mon, 12/27/2021 - 15:34. Tags. Articles.
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
Scienmag
DECEMBER 29, 2021
UCL press release Under embargo until Wednesday 29 December, 22:00 UK time / 17:00 US Eastern time Credit: Picturing Health, picturinghealth.org UCL press release Under embargo until Wednesday 29 December, 22:00 UK time / 17:00 US Eastern time Peer-reviewed / Randomised controlled trial / People Easy-to-take medicine better at suppressing HIV in children A once-a-day […].
Pharma Packaging Solutions
DECEMBER 28, 2021
We’ve likely all experienced beautiful sunrises in various places. Perhaps a never-ending ocean? An expansive high desert where one can see forever? A peaceful Smoky Mountain lookout? The broad Texas or Oklahoma plains? Your own backyard with multicolored sky? We’re reminded that day is not ending, but gloriously beginning. “O Holy Night” gives us imagery of the first Advent with the line, “for yonder breaks a new and glorious morn.
Drug Patent Watch
DECEMBER 27, 2021
Annual Drug Patent Expirations for ACCUNEB Accuneb is a drug marketed by Mylan Speciality Lp and is included in one NDA. It is available from one supplier. There is one…. The post New patent expiration for Mylan Speciality drug ACCUNEB appeared first on DrugPatentWatch - Make Better Decisions.
BioTech 365
DECEMBER 29, 2021
United States Artificial Intelligence (AI) In Drug Discovery Market Research Report 2021: Prospects, Trends Analysis, Market Size and Forecasts to 2027 – ResearchAndMarkets.
Advertisement
Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.
Expert insights. Personalized for you.
191 
Let's personalize your content